Publicacións nas que colabora con Jesús Pérez Losada (19)

2013

  1. CD133+ cell content correlates with tumour growth in melanomas from skin with chronic sun-induced damage

    British Journal of Dermatology, Vol. 169, Núm. 4, pp. 830-837

2012

  1. New models towards assessing anti-cancer therapeutics

    Histology and Histopathology, Vol. 27, Núm. 2, pp. 157-170

2010

  1. Cancer as a reprogramming-like disease: Implications in tumor development and treatment

    Seminars in Cancer Biology, Vol. 20, Núm. 2, pp. 93-97

  2. New functions for the Snail family of transcription factors: Two-faced proteins

    Cell Cycle

  3. The evolution of cancer modeling: The shadow of stem cells

    DMM Disease Models and Mechanisms

2009

  1. Elimination of cancer stem cells

    Stem Cell Biology in Health and Disease (Springer Netherlands), pp. 357-384

2008

  1. The Emerging Picture of Human Breast Cancer as a Stem Cell-based Disease

    Stem Cell Reviews, Vol. 4, Núm. 2, pp. 67-79

2003

  1. Deletion of the SLUG (SNAI2) gene results in human piebaldism

    American Journal of Medical Genetics, Vol. 122 A, Núm. 2, pp. 125-132

  2. The radioresistance biological function of the SCF/kit signaling pathway is mediated by the zinc-finger transcription factor Slug

    Oncogene, Vol. 22, Núm. 27, pp. 4205-4211

2002

  1. Expression of the FUS domain restores liposarcoma development in CHOP transgenic mice

    Oncogene, Vol. 21, Núm. 11, pp. 1679-1684

  2. SLUG (SNA12) deletions in patients with Waardenburg disease

    Human Molecular Genetics, Vol. 11, Núm. 25, pp. 3231-3236

  3. Understanding mesenchymal cancer: The liposarcoma-associated t(12;16) (q13;p11) chromosomal translocation as a model

    Current Genomics, Vol. 3, Núm. 4, pp. 237-244

  4. Zinc-finger transcription factor slug contributes to the function of the stem cell factor c-kit signaling pathway

    Blood, Vol. 100, Núm. 4, pp. 1274-1286

2001

  1. Philadelphia-positive B-cell acute lymphoblastic leukemia is initiated in an uncommitted progenitor cell

    Leukemia and Lymphoma, Vol. 42, Núm. 4, pp. 569-576

  2. Selective destruction of tumor cells through specific inhibition of products resulting from chromosomal translocations

    Current Cancer Drug Targets, Vol. 1, Núm. 2, pp. 109-119

2000

  1. A primitive hematopoietic cell is the target for the leukemic transformation in human Philadelphia-positive acute lymphoblastic leukemia

    Blood, Vol. 95, Núm. 3, pp. 1007-1013

  2. Liposarcoma initiated by FUS/TLS-CHOP: The FUS/TLS domain plays a critical role in the pathogenesis of liposarcoma

    Oncogene, Vol. 19, Núm. 52, pp. 6015-6022

  3. The chimeric FUS/TLS-CHOP fusion protein specifically induces liposarcomas in transgenic mice

    Oncogene, Vol. 19, Núm. 20, pp. 2413-2422

1998

  1. Chromosomal abnormalities and tumor development: FRom genes to therapeutic mechanisms

    BioEssays, Vol. 20, Núm. 11, pp. 922-930